![](https://webarchive.library.unt.edu/eot2008/20090118173125im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Rulemaking History for OTC Dandruff, Seborrheic, Dermatitis and Psoriasis Drug Products View by Date
Final Monograph (21 CFR part 358 subpart H):
Miscellaneous External Drug Products for Over-the-Counter Human Use:
Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products
|
OTC Dandruff, Seborrheic, Dermatitis and Psoriasis Drug Products found on this page:
Back to Top
Back to Rulemaking Index
Date created: December 28, 2006; Last updated: May 4, 2007 |
![](https://webarchive.library.unt.edu/eot2008/20090118173125im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |